Barclays Downgrades Pacific Biosciences of California (PACB) to Underweight
Tweet Send to a Friend
(Updated - March 6, 2026 6:20 AM EST)
Barclays analyst Luke Sergott downgraded Pacific Biosciences of California (NASDAQ: PACB) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst Luke Sergott downgraded Pacific Biosciences of California (NASDAQ: PACB) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
